vTv Therapeutics Inc (VTVT)
Healthcare
Biotechnology
32.40 $
-1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns vTv Therapeutics Inc (VTVT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 54.4% of the shares are freely tradable; institutional investors hold 38.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
38.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
39.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
54.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
4Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Samsara BioCapital, LLC | 7.58 | 298,496 | +0.0 | 03/31/2026 |
| FMR Inc | 6.61 | 260,391 | -3.1 | 03/31/2026 |
| Millennium Management LLC | 5.24 | 206,288 | +0.0 | 03/31/2026 |
| Siren, L.L.C. | 4.14 | 163,000 | +0.0 | 03/31/2026 |
| Baker Bros Advisors LP | 3.77 | 148,314 | +0.0 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 3.54 | 139,578 | -39.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.77 | 108,922 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.12 | 83,400 | +77.5 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Select Biotechnology | 6.61 | 260,391 | +0.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 1.89 | 74,346 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.